Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-24 @ 7:11 PM
NCT ID:
NCT05512403
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 75 years old
* WHO general condition ≤2
* Identification of a unifocal brain tumour at the initial diagnosis with no contrast in the MRI and suspected to be a LGG, with biopsy/surgery envisaged within 6 months of the PET scan
* MRI performed a maximum of 3 weeks before inclusion and comprising the conventional morphological sequences (T1, T1 sequences with injection of contrast agent and T2 FLAIR).
* Subject affiliated to or beneficiary of a social security plan
* Subject having received complete information on the organisation of the research and having signed the informed consent form.
Exclusion Criteria:
* Multifocal brain lesions
* Contraindication to 18F-FDOPA PET
* Pregnant, parturient women or nursing mothers under Article L1121-5
* Women of childbearing age who do not have effective contraception under Article L1121-5
* Monitoring not possible
* Persons deprived of their liberty by a judicial or administrative decision under Article 1121-8, persons undergoing psychiatric treatment under Articles L. 3212-1 and L. 3213-1.
* Patients cannot simultaneously participate in an interventional research trial for the duration of the KING study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05512403
Study Brief:
Protocol Section:
NCT05512403